Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

Clinical Outcomes Versus Biomarker Improvements

A biomarker, such as mitochondrial respiration or ATP production, may help explain mechanism. A clinical outcome, such as walking distance, heart function, hospitalization, fatigue improvement, or survival, determines whether a therapy helps patients in a mean

This comparison does not assign a generated winner or score.

  • A biomarker, such as mitochondrial respiration or ATP production, may help explain mechanism. A clinical outcome, such as walking distance, heart function, hospitalization, fatigue improvement, or survival, determines whether a therapy helps patients in a meaningful way 20.
  • For SS-31, this distinction is essential. Mitochondrial function with SS-31 may improve in some models, but clinical outcomes require direct evidence.
More references

Related material

Comparison

SS-31 versus MOTS-c

Both peptides target mitochondria but through fundamentally different mechanisms. SS-31 physically stabilizes mitochondrial membranes by binding cardiolipin. MOTS-c activates meta…

View details →
Comparison

SS-31 versus CoQ10

Coenzyme Q10 serves as an electron carrier in the mitochondrial membrane. Supplementation can improve mitochondrial function in those with depleted levels, particularly older indi…

View details →
Comparison

SS-31 versus NAD+ precursors

NMN and NR boost NAD+ levels, supporting sirtuin activity and mitochondrial enzyme function. They are readily available as supplements without the legal ambiguity of research pept…

View details →